Mylan Pharmaceuticals in Morgantown will shut down next summer, eliminating 15-hundred jobs. Viatris, the company that owns the plant, says up to twenty-percent of it global workforce may be affected by restructuring. The company completed a merger last month the Pfizer’s Upjohn unit. The site has produced medicine since 1965.